Press release
Competitive Landscape: Leading Companies and New Entrants in the Neuropathic Pain Market
Neuropathic Pain Market
Projected Growth and Market Value of the Neuropathic Pain Market
The neuropathic pain market is anticipated to experience robust growth over the coming years, reaching a valuation of $8.48 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 8.1%. Several factors are fueling this growth, including a shift toward non-opioid treatment options, rising demand for tailored pain management strategies, wider adoption of complementary therapies, increased investments in diagnostic innovation, and the development of sophisticated multimodal treatment methods. Prominent trends expected to influence the market during this period include greater use of multimodal therapies, preference for non-opioid pain control, integration of physical and psychological therapies, enhanced early diagnosis through advanced imaging, and a focused approach toward treating diabetic neuropathy.
Download a free report of the neuropathic pain market report:
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Key Factors Encouraging Non-Opioid Treatment Adoption
One of the main drivers behind the neuropathic pain market's rise is the growing preference for non-opioid therapies. This trend reflects a broader healthcare movement to minimize opioid use due to concerns about addiction and side effects. Patients and clinicians alike are increasingly turning to alternative treatments that offer effective pain relief without the risks associated with opioids.
Rising Demand for Personalized Pain Management Solutions
Another significant influence on market growth is the increasing demand for individualized pain management. As medical technology advances, treatments are becoming more customized to patient needs, improving outcomes and patient satisfaction. This push toward personalization is encouraging the development of new therapies and diagnostic techniques that address the unique characteristics of neuropathic pain in different individuals.
View the full neuropathic pain market report:
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Shaping the Neuropathic Pain Sector
Several major pharmaceutical and biotech companies are playing influential roles in the neuropathic pain market. Notable organizations include Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol?Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline Plc, Medtronic Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., Nevro Corp., InvaGen Pharmaceuticals Inc., Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, Novartis AG, Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Assertio Therapeutics Inc., NeuroMetrix Inc., and OMRON Healthcare Co Ltd.
Strategic Acquisition Enhancing Novartis AG's Neuropathic Pain Portfolio
In a notable move in July 2023, Novartis AG, a global pharmaceutical leader headquartered in Switzerland, acquired US-based biotechnology firm DTx Pharma. Though the financial details were not disclosed, this acquisition strengthens Novartis's capabilities in developing small interfering ribonucleic acid (siRNA) therapies targeted at neurological disorders, including neuropathic pain. DTx Pharma specializes in RNA-based therapeutic development at the preclinical stage, aiming to address unmet medical needs and accelerate the delivery of innovative treatments to patients.
Comprehensive Segments Covered in the Neuropathic Pain Market
The neuropathic pain market report categorizes the industry into distinct segments for in-depth analysis:
1) Treatment Types: Medications and Multimodal Therapy
2) Diagnostic Methods: Imaging, Blood Tests, and Physical Examination
3) Indications: Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, and Other Conditions
4) End Users: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, and Other Facilities
Detailed Subsegments Within the Market
The report further breaks down the segments to provide granular insights:
- Medications include anticonvulsants, antidepressants, opioids, topical treatments, and non-steroidal anti-inflammatory drugs (NSAIDs)
- Multimodal therapy covers combinations of medications, physical therapy, psychological therapy, lifestyle modifications, and complementary therapies
This structured approach to segmenting the neuropathic pain market helps stakeholders understand the diverse treatment options, diagnostic advancements, and care settings that are shaping this evolving healthcare field.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Competitive Landscape: Leading Companies and New Entrants in the Neuropathic Pain Market here
News-ID: 4483183 • Views: …
More Releases from The Business Research Company
Competitive Landscape: Key Market Leaders and Rising Competitors in the Contrace …
The contraceptives market is positioned for significant expansion over the coming years, driven by innovation and growing awareness about reproductive health. Advances in technology, evolving consumer preferences, and broader access to contraceptive options are shaping this dynamic industry. Below is a detailed overview of the market size, key players, prevailing trends, and segmentation.
Forecasted Growth and Market Size of the Contraceptives Market by 2030
The contraceptives market is projected to…
Growth Patterns, Market Segmentation, and Competitive Approaches Influencing the …
The constrained peptide drugs market is attracting significant attention due to its promising growth potential and innovative therapeutic applications. As the pharmaceutical industry advances, these specialized peptides are expected to revolutionize treatment options for complex diseases, offering improved efficacy and targeted delivery. Here's a detailed exploration of the market's size, key players, emerging trends, and major segments shaping its future.
Projected Market Value and Growth Rates for Constrained Peptide Drugs …
Segmentation, Major Trends, and Competitive Overview of the Conjugated Monoclona …
The conjugated monoclonal antibodies market is on track for significant expansion over the coming years, driven by advancements in technology and increased adoption in cancer treatment. This segment holds promising potential as it evolves with new innovations and growing investment in oncology research. Let's explore the current market valuation, key players, emerging trends, and the main segments shaping the future of conjugated monoclonal antibodies.
Projected Market Valuation and Growth Path of…
Leading Companies Reinforcing Their Presence in the Compression Therapy Market
The compression therapy industry is poised for remarkable expansion as healthcare continues to evolve with new technologies and growing patient needs. This sector is becoming increasingly vital, especially for managing vascular and circulatory conditions, with innovations driving greater adoption and improved outcomes. Below is a detailed look at the market's size, key players, influential trends, and segmentation.
Compression Therapy Market Size Set for Significant Growth by 2030
The compression therapy…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
